Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

4-Hydroxy-8-Bromoquinoline

    • Product Name 4-Hydroxy-8-Bromoquinoline
    • Alias 8-Bromo-4-quinolinol
    • Einecs 626-664-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    213945

    Chemical Name 4-Hydroxy-8-Bromoquinoline
    Molecular Formula C9H6BrNO
    Molecular Weight 224.06 g/mol
    Cas Number 26645-51-2
    Appearance Solid, off-white to pale yellow
    Melting Point 170-172°C
    Solubility Slightly soluble in water, soluble in organic solvents
    Purity Typically >98%
    Structure Quinoline core with hydroxy group at position 4 and bromo group at position 8

    As an accredited 4-Hydroxy-8-Bromoquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 4-Hydroxy-8-Bromoquinoline

    Applications of 4-Hydroxy-8-Bromoquinoline in Industrial Manufacturing

    As a dedicated manufacturer of 4-Hydroxy-8-Bromoquinoline, we support clients in tightly regulated and innovation-driven sectors where this advanced quinoline derivative functions as a core intermediate. Below, we outline its established industrial roles with scenario-specific process, compliance, and usage details based on active customer projects and regulatory requirements.

    1. Pharmaceutical Intermediate for Antimalarial API Synthesis

    4-Hydroxy-8-Bromoquinoline serves as a critical building block in the targeted synthesis of select antimalarial active pharmaceutical ingredients (APIs), including derivatives developed for resistance management. Pharmaceutical producers incorporate this intermediate in multi-step organic synthesis, enabling precise halogen placement and hydroxy group introduction required by therapeutic compound frameworks. Input quality, process consistency, and regulated impurity control are essential throughout preclinical and commercial production pipelines.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients
    • Current USP/EP monographs for related quinoline APIs
    • Guidance from U.S. FDA, EMA, and China NMPA regarding starting/intermediate substance control
    • REACH registration for handling in Europe

    Typical usage ratio

    • Employed typically at 1.2–1.8 molar equivalents relative to the final API scaffold, adjusted for yield efficiency and downstream purification needs

    Downstream process integration

    • Introduced during the stage of halogen exchange and hydroxy functionalization before subsequent amination or side-chain modifications
    • Used as the second or third intermediate depending on specific API pathway
    • Feedstock dissolved in aprotic solvent under nitrogen to prevent degradation during coupling

    Final product types

    • Antimalarial finished dosage forms such as tablets and suspensions
    • Branded and generic antimalarial APIs (e.g., novel 4-substituted quinolines)
    • Precursor compounds for pharmaceutical development under clinical trial

    2. Agrochemical Active Compound Synthesis

    Specialty agrochemical manufacturers use 4-Hydroxy-8-Bromoquinoline to synthesize certain crop protection agents, especially fungicide and pesticide actives targeting resistant pest strains. Its molecular framework offers targeted bromination and hydroxylation sites crucial to the synthesis of unique quinoline-based bioactives. Downstream producers rely on purity consistency for reliable field performance and regulatory residue compliance in market-ready formulations.

    Industry compliance standards

    • FAO/WHO Specification for Agricultural Pesticides (including requirements for active contents and impurities)
    • Regulations set by U.S. EPA, EU PPP Regulation (EC) No 1107/2009
    • ISO 9001:2015 Quality Management System for agrochemical intermediates
    • China GB/T 20784 standard for pesticide intermediates

    Typical usage ratio

    • Added in 5–15% w/w as a core intermediate in multi-step synthesis, with precise adjustment by formulation chemists based on target yield, downstream reactivity, and solvent system

    Downstream process integration

    • Feeds into bromination or hydroxy group-preserving cyclization reactors, commonly right before the final coupling or functionalization that imparts pesticide activity
    • In-process monitoring tracks byproduct removal at this stage to meet active ingredient registration standards

    Final product types

    • Technical grade fungicides (e.g., quinoline or naphthyridine-based)
    • High-value specialty pesticides
    • Seed treatments and agricultural chemical formulations

    3. Synthesis of Heterocyclic Specialty Dyes and Pigments

    Heterocycle dye and pigment manufacturers employ 4-Hydroxy-8-Bromoquinoline as a precursor to generate bromoquinoline-based chromophores. Its chemical structure offers development labs multiple points for further substitutions, leading to stable, lightfast dyes compatible with high-performance textile, ink, and polymer matrix applications. Partners emphasize the need for narrow impurity profiles and reliable bromine content to ensure reproducible color yield.

    Industry compliance standards

    • OEKO-TEX Standard 100 and ZDHC MRSL for restricted substances in textile dyes
    • ISO 9001 and ISO 14001 certification for environmental and product quality control
    • EU REACH Annex XVII compliance for dye substances
    • EN 71-3 for toy safety and dye trace element restrictions

    Typical usage ratio

    • Used in final pigment synthesis at 3–10% w/w of total chromophore mass, with the exact proportion set by product color intensity and batch scale

    Downstream process integration

    • Charged during heterocyclic condensation, substituted bromo-hydroxy group conversion, or direct metal complexation steps
    • Monitored during oxidative coupling reactions for pigment crystal growth

    Final product types

    • Solvent-stable specialty organic pigments for plastics and coatings
    • Reactive textile dyes for cellulosic fibers
    • High-color-fast inks for industrial printing

    4. Chemical Building Block for Electronic Materials

    Producers of custom electronic and photonic materials integrate 4-Hydroxy-8-Bromoquinoline as a versatile intermediate in constructing advanced organic semiconductors and functionalized polymers. The bromo and hydroxy substituents enable site-selective reactions leading to tuneable electronic properties. Applications include the development of charge transport layers and organic electronics materials requiring consistent purity and regulated trace metal content.

    Industry compliance standards

    • IEC 60747 and IPC-4101 specification for organic electronic material quality
    • ISO 14644 cleanroom production standards
    • RoHS Directive (EU) 2011/65/EU for restriction of hazardous substances in electronics
    • ISO 9001:2015 for quality management and batch traceability

    Typical usage ratio

    • Incorporated at 1–6% by weight relative to main polymer or semiconductor matrix, optimized for charge mobility and layer uniformity as determined during scale-up trials

    Downstream process integration

    • Dosed during condensation polymerization or Suzuki–Miyaura cross-coupling to introduce functionalized units into backbone or as terminal modifiers
    • Strictly monitored for halogen purity and hydroxy content at this stage

    Final product types

    • Functionalized conjugated polymers for organic light-emitting diodes (OLEDs)
    • Organic field effect transistor (OFET) channel semiconductors
    • Photonic device layers and thin-film electronics materials

    5. Intermediate for Fluorescent Probe Synthesis in Diagnostics

    Diagnostic reagent and life science kit manufacturers source this material as an intermediate in synthesizing advanced quinoline-based fluorescent probes. Its distinct substitution pattern supports strong fluorescence and tailored sensor binding sites, making it valuable for the development of reagents used in clinical sample analysis, flow cytometry, and high-sensitivity bioassays. Reliable impurity content and batch uniformity directly affect end-product performance in regulated laboratory environments.

    Industry compliance standards

    • ISO 13485 for medical device and diagnostic reagent manufacturing
    • FDA 21 CFR Part 820 Quality System Regulation (for clinical diagnostics)
    • CLSI (Clinical and Laboratory Standards Institute) guidance for assay reagents
    • Restriction of hazardous substances to EU RoHS for diagnostics supplied in Europe

    Typical usage ratio

    • Utilized at 2–8% w/w within fluorophore synthesis, dosage determined by desired fluorescence intensity and probe calibration requirements

    Downstream process integration

    • Employed during late-stage coupling or cyclization steps to fix chromophore structure and optimize emission properties
    • Subsequently purified by crystallization or chromatography to meet analytical-grade specifications

    Final product types

    • Ready-to-use fluorescent probes for molecular diagnostics
    • Spectral tags for immunoassays and flow cytometry reagents
    • Research-use-only (RUO) reagents for biomedical and life science laboratories
    Free Quote

    Competitive 4-Hydroxy-8-Bromoquinoline prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    4-Hydroxy-8-Bromoquinoline: Introducing a Distinctive Reagent for Advanced Research

    Exploring the Profile of 4-Hydroxy-8-Bromoquinoline

    My experience in chemical research has shown that every shift in a compound’s structure can bring a new dimension to its behavior. The introduction of 4-Hydroxy-8-Bromoquinoline communicates this idea with clarity. Rooted in the trusted quinoline scaffold, this molecule stands out because of its specific substitutions at the 4 and 8 positions, which set it apart from more commonly known analogues. That substitution — where a hydroxy group anchors itself at the fourth carbon and a bromine at the eighth — isn’t just a slight tweak. It shifts reactivity, solubility, and the compound’s potential roles in organic synthesis, medicinal chemistry, and other sophisticated labs.

    Analytical chemists might remember quinoline itself as an old workhorse in heterocyclic chemistry. Yet, with each new substituent, unique possibilities emerge. While hydroxy groups can encourage hydrogen bonding and increase polarity, the presence of bromine introduces a heavier atom and leapfrogs conventional expectations, especially for those interested in further derivatization or cross-coupling chemistry. The role of such adjustments can be seen in the surge of innovative syntheses and drug discovery paths that were closed to standard quinoline frameworks.

    Model Highlights and Chemical Character

    In the setting of modern laboratories, having a compound like 4-Hydroxy-8-Bromoquinoline on the shelf reflects more than access to diverse reagents. For those probing new routes in organic synthesis, this molecule brings the reliability of crystalline form, a well-defined melting point, and solid persistence under most storage conditions. These properties aren't decorative — they’re foundational for accuracy during preparation and making sure that reactions yield consistent results. The hydroxy group settles into chemistry by enhancing water compatibility, while the bromine atom catches the attention of practitioners working with transition metal catalysis. After years at the bench, these features feel meaningful because they shave hours off purification and open up iterative experimentation.

    Taking the typical model, the molecular weight is heavier due to bromine’s inclusion, which can benefit chemists aiming to track their products during high-resolution mass spectrometry or NMR analysis. Chemical purity levels, which chemists demand, often reach above 98 percent for such specialty building blocks. Consistency in lot-to-lot performance hits the mark, avoiding the pitfalls that sometimes dog more novel or less stabilized compounds. For me and many others, this means you move forward in research, not sideways correcting for hidden impurities or erratic yields.

    Applications in Chemistry and Beyond

    As research continues to stretch into areas like medicinal chemistry, photochemical research, and materials science, the value of unique heterocycles cannot be overstated. 4-Hydroxy-8-Bromoquinoline works as a key intermediate when building up new drug candidates. Medicinal chemists, thinking about the next kinase inhibitor or antimicrobial prototype, often reach for quinoline frameworks due to their known biological activity. The hydroxy group isn’t just a hydrophilic handle; it serves as a crucial entry point for substitution reactions, fostering the rapid assembly of libraries that drive SAR (structure-activity relationship) studies.

    Bromination at the eighth position delivers another advantage. For those working with Suzuki or Heck coupling reactions, the presence of a reactive halogen on the aromatic ring can be a game-changer. This offers a clear route for linking new groups, expanding the utility of the quinoline, or even fixing sites for labeling in complex molecules. The importance here isn’t theoretical; it’s what makes late-stage diversification and lead optimization possible. In my lab, the flexibility to quickly modify molecular frameworks translates into shorter timelines between idea and tangible results.

    Real-World Laboratory Experience and Solutions

    Lab life rarely goes as planned, and that’s where the specific properties of 4-Hydroxy-8-Bromoquinoline show their worth. Its balance of reactivity simplifies purification, with the hydroxy group often allowing for basic extraction methods, while the bulky bromine discourages overreaction. Challenges come up in scale-up, as bromoquinolines sometimes suffer from unpredictability under oxidative conditions. Addressing this isn’t about switching to another scaffold but adjusting protocols: chemists often add protective atmospheres, stronger scavenging, and slower temperature ramps during scale-up to safeguard both yield and product identity.

    Research leaders also face the need to minimize waste and solvent impact. Here, 4-Hydroxy-8-Bromoquinoline’s solubility in common organics such as DMSO and DMF enables more concentrated, thus cleaner, processes. The ability to filter, wash, and dry without losing product to waste bins eventually matters for green chemistry goals. Peers in process chemistry note that with reliable analytics, including TLC, melting point, and spectral data, troubleshooting becomes more about interpretation than guesswork.

    The Edge Over Standard Quinoline Derivatives

    Anyone with time in chemical development understands the frustration of marginal gains — the long slog for tiny improvements. Switching to 4-Hydroxy-8-Bromoquinoline from non-halogenated or unsubstituted quinolines shortens that journey. The presence of bromine aligns with a wave of discoveries in palladium-catalyzed coupling, which continue to reshape what can be achieved with aromatic and heterocyclic scaffolds. This also makes it attractive to synthetic chemists who wish to functionalize compounds with precision, avoiding random halogen substitutions later in a sequence.

    Some may argue that simple hydroxyquinolines or plain bromoquinolines cover most use cases. My experience says otherwise. In medicinal chemistry, for example, the synergy between hydroxy and bromo groups can dial in on-target activity or tweak pharmacokinetics, sometimes moving a project forward where less decorated compounds stall. Material scientists, too, notice different fluorescence, color, or binding properties when subtle changes hit the molecule’s core. These aren’t embellishments for a catalog—they’re critical levers for innovation.

    Addressing Existing Challenges in Research and Development

    No matter the chemical’s potential, researchers confront real barriers. Price and availability, sometimes volatile due to supply chain hiccups with halogenated precursors, can block work before it starts. Some colleagues lament long waits for custom synthesis or extended lead times from specialty vendors. Having strong relationships with reliable suppliers — those who produce in GMP-like environments and keep quality standards transparent — often spells the difference between on-time progress and indefinite delay. That open conversation with suppliers, built over years of exchange and feedback, feels as vital as pipetting skills at the bench.

    Another issue is the environmental profile of halogenated reagents. Bromine, while offering reactivity, brings up questions of downstream waste and human safety in both small- and large-scale settings. Process development teams respond with rigorous containment, micro-scale reaction trials, and solvent recovery, all designed to not only save costs but also prevent regulatory headaches. This approach turns the environmental profile of 4-Hydroxy-8-Bromoquinoline from a liability into a manageable challenge, echoing broader chemical industry trends toward responsible innovation.

    Building on Experience and Evidence-Based Principles

    Anyone working in a lab for long comes to recognize that methodical, evidence-based practice brings real-world benefits. Sourcing 4-Hydroxy-8-Bromoquinoline from reputable suppliers reduces variability, which in turn helps laboratories produce results that stand up to peer review — not just internal reporting. In the age of increasingly strict scientific publishing standards, this attention to quality can’t be skipped.

    Ethical practice, an echo of guidelines for experience, expertise, authority, and trust, leads researchers away from gray-market reagents or loosely characterized material. It shows respect for the scientific method, worker safety, and patient wellbeing in end applications. 4-Hydroxy-8-Bromoquinoline reflects this, with widespread demand pushing suppliers to certify purity, screen for heavy-metals residue, and offer comprehensive analytical documentation. That documentation, beyond regulatory compliance, lets researchers interrogate their work and build reproducible protocols. I’ve seen how a well-placed certificate of analysis boosts confidence, especially in collaborative projects crossing institutions and borders.

    Potential and Future Outlook

    Chemistry is a field where yesterday’s curiosity becomes today’s necessity. New research directions often rely on having access to specialty compounds like 4-Hydroxy-8-Bromoquinoline. While it isn’t a household name, its structural features, namely the interplay between the hydroxy and bromo functional groups, continue to expand options in biological assays, molecular electronics, and asymmetric synthesis.

    More recently, interest in targeted drug delivery systems has sparked investigations into derivative formation. By attaching targeting ligands or payloads at the hydroxy group, researchers have the power to engineer molecules for maximal specificity. The bromine’s role as a synthetic anchor further enables late-stage diversification without backtracking. In material science, photophysical studies of substituted quinolines confirm that such substitutions modify absorption and emission, sometimes unlocking new optical or electronic properties for sensors or organic semiconductors.

    Solutions for Sustainability and Safety

    Tackling safety and sustainability isn’t just about making green statements. Researchers put safety front and center by working in ventilated enclosures, adhering to proven protocols for waste segregation, and reviewing literature for improved reaction conditions. For compounds like 4-Hydroxy-8-Bromoquinoline, which attract attention from both academic and industrial actors, building safer protocols can include moving to solid-phase or microwave-assisted methods that reduce exposure and waste.

    Chemical recycling and reuse programs, increasingly mandated by institutions or local ordinances, find added value here. The molecule’s physical properties, including distinct solubility in polar solvents, lend themselves to straightforward recovery steps. For small labs, this might mean reusing chromatography eluents, while for larger operations, it might involve closed-loop solvent systems. Such steps don’t just cut costs but demonstrate commitment to best practices that extend beyond regulatory compliance.

    Community Knowledge Sharing and Ongoing Improvements

    Forums, symposia, and peer-reviewed journals all help build a knowledge base around how to get the best out of specialty chemicals. With 4-Hydroxy-8-Bromoquinoline, success stories often come from those willing to share honest feedback about failed approaches or surprising reactivity. Labs can benefit from reviewing these communal resources since repeated trial and error rarely beats hard-earned advice succinctly shared by peers.

    Accessible data sets, including NMR fingerprints and LC-MS traces provided openly by suppliers or user communities, allow chemists to troubleshoot before running costly reactions. Years of observation suggest that a spirit of transparency — data available for scrutiny, willingness to disclose setbacks, encouragement for new users to contribute — paves the way for more reliable and imaginative research.

    Distinctiveness and Market Context

    Specialty chemicals have carved out their own segment in the global market, driven by research teams that recognize the gains from precise molecular design. 4-Hydroxy-8-Bromoquinoline responds to a need for fine-tuned intermediates and analytical reference standards that generic chemicals can’t satisfy. This is particularly relevant for pharmaceutical firms and academic research groups active in heterocyclic modification, as competitive timeframes and intellectual property stakes run high.

    Competition has improved quality. The number of suppliers who offer detailed spectral data, strong after-sales support, and access to technical teams has grown. Industry analysts note a clear movement towards integration — not just producing the molecule, but supporting it through every stage of customer engagement, from order to application troubleshooting. In my experience, this trend supports a more resilient chemical research ecosystem, offering both choice and confidence to those making critical purchases.

    Looking Forward: Building on Strengths and Experience

    Research, development, and innovation don’t stand still. New protocols, equipment, and demands drive the evolution of chemical libraries. 4-Hydroxy-8-Bromoquinoline sits among those building blocks whose true impact depends on both reliability and the creativity of those using them. Whether in the design of a new pharmaceutical candidate, the trial run of a catalytic reaction, or the assembly of an optoelectronic device, its presence is felt in the small yet critical ways that only those familiar with the grind of benchwork can fully appreciate.

    Building trust in specialty reagents comes from collective effort: suppliers who meet evolving standards, researchers who engage critically and share lessons learned, and institutions that foster open information flow. The ongoing refinement of 4-Hydroxy-8-Bromoquinoline, informed by evidence and real technical demands, points to a rich future for structured chemical innovation.

    Closing Thoughts on Value and Application

    Across research communities, the right specialty compound can hasten discovery, smooth out development pitfalls, and unlock creative routes in synthesis and analysis. 4-Hydroxy-8-Bromoquinoline demonstrates this potential. Rooted in a legacy of quinoline chemistry yet unmistakably unique, its specific balance of hydroxy and bromo substituents invites experimentation and delivers reliable performance. The face of modern research, marked by rapid iteration and unrelenting standards, finds a relevant tool here. As the field presses forward, the experiences, data, and best practices built around this compound strengthen the scaffolding for breakthroughs yet to come.